Guidelines for the prevention of secondary lymphedema following breast cancer treatment

adhesion and associated factors

Authors

Keywords:

breast neoplasms, lymphedema, physical therapy modalities, disease prevention

Abstract

Introduction: Lymphedema is the most feared complication that may take place after breast cancer treatment. With treatment progression, doubts have arisen regarding the real benefits of lymphedema prevention care, as well as of patient adherence to guidelines. Objective: In this context, the aim of this study was to assess patient adherence to preventive lymphedema guidelines and the distribution of sociodemographic, clinical, and treatment variables according to adherence to treatment. Methods: A cross‑sectional study conducted at the Cancer Hospital III/INCA, Rio de Janeiro, Brazil, concerning patients with breast cancer undergoing surgical treatment with an axillary approach. Participants were questioned about assistance care performance, exercise‑related care, and limb ipsilateral to surgery care. A descriptive analysis of patient demographic, clinical, treatments, postoperative complications variables, and main outcomes (adherence to the guidelines) was performed through a central tendency measure and data dispersion and frequency measures analyses. Differences between means were assessed using the Student’s t‑test, while differences between proportions were evaluated using the chi‑square test. A significance level of 5% was considered for all assessments. Results: Of the 103 women included in this study, 89.3% adhered to assistance care, 61.2% adhered to limb care, and 42.7% performed exercise‑related care. Women undergoing chemotherapy (p = 0.030) and axillary lymphadenectomy (AL) (p = 0.017) exhibited greater adherence to care. Non‑white patients (p = 0.048) and those who underwent AL (p = 0.025) adhered to limb care more frequently. Finally, patients displaying lower education levels (p = 0.013) and those who underwent AL (p = 0.009) adhered more frequently to limb exercises. Conclusion:Patients adhered the most to assistance care and limb care compared to exercise practice. Patients undergoing chemotherapy displayed greater adherence to care and non‑white patients adhered the most to limb care. Women who underwent AL displayed greater adherence to all types of care and those presenting lower education levels adhered more frequently to exercise guidelines.

Downloads

Download data is not yet available.

Author Biographies

Erica Alves Nogueira Fabro, Brazilian National Cancer Institute

Physiotherapy Department, Cancer Hospital III, Brazilian National Cancer Institute – Rio de Janeiro (RJ), Brazil.

Flávia Oliveira Macedo, Brazilian National Cancer Institute

Physiotherapy Department, Cancer Hospital III, Brazilian National Cancer Institute – Rio de Janeiro (RJ), Brazil.

Rejane Medeiros Costa, Brazilian National Cancer Institute

Physiotherapy Department, Cancer Hospital III, Brazilian National Cancer Institute – Rio de Janeiro (RJ), Brazil.

Marianna Brito de Araújo Lou, Brazilian National Cancer Institute

Physiotherapy Department, Cancer Hospital III, Brazilian National Cancer Institute – Rio de Janeiro (RJ), Brazil.

Liz de Oliveira Marchito, Samaritano Hospital

Physiotherapy Department, Samaritano Hospital – Rio de Janeiro (RJ), Brazil.

Suzana Sales de Aguiar, Brazilian National Cancer Institute

Clinical Research Division, Brazilian National Cancer Institute – Rio de Janeiro (RJ), Brazil.

Anke Bergmann, Brazilian National Cancer Institute

Clinical Research Division, Brazilian National Cancer Institute – Rio de Janeiro (RJ), Brazil

References

Instituto Nacional de Câncer José Alencar Gomes da Silva. Estimativa 2020: incidência de câncer no Brasil. Rio de Janeiro: INCA; 2019.2. Globocan. The Global Cancer Observatory [Internet].

Globocan; 2020 [cited on Feb 1, 2021]. Avaiable at: https://gco.iarc.fr/today

Instituto Nacional de Câncer José Alencar Gomes da Silva. A situação do câncer de mama no Brasil: síntese de dados dos sistemas de informação. Rio de Janeiro: INCA; 2019.

Fabro EAN, Bergmann A, Amaral e Silva B, Padula Ribeiro AC, Souza Abrahão K, Ferreira MGCL, et al. Post-mastectomy pain syndrome: incidence and risks. Breast. 2012;21(3):321-5. https://doi.org/10.1016/j.breast.2012.01.019

Abrahão KS, Bergmann A, Aguiar SS, Thuler LC. Determinants of advanced stage presentation of breast cancer in 87,969 Brazilian women. Maturitas. 2015;82(4):365-70. https://doi.org/10.1016/j.maturitas.2015.07.021

Macedo FO, Bergmann A, Koifman RJ, Torres DM, Costa RM, da Silva IF. Axillary surgery in breast cancer: acute postoperative complications in a hospital cohort of women of Rio de Janeiro, Brazil. Mastology. 2018;28(2):80-6. https://doi.org/10.29289/2594539420180000377

McLaughlin SA, Bagaria S, Gibson T, Arnol M, Diehl N, Crook J, et al. Trends in risk reduction practices for the prevention of lymphedema in the first 12 months after breast cancer surgery. J Am Coll Surg. 2013;216(3):380-9. https://doi.org/10.1016/j.jamcollsurg.2012.11.004

Executive Committee of the International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2020 Consensus Document of the International Society of Lymphology. Lymphology. 2020;53(1):3-19.

Bergmann A, Mattos IE, Koifman RJ. Incidence and prevalence of lymphedema after breast cancer surgery: literature review. Rev Bras Cancerol. 2007;53(4):461-70.

DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500-15. https://doi.org/10.1016/S1470-2045(13)70076-7

Torgbenu E, Luckett T, Buhagiar MA, Chang S, Phillips JL. Prevalence and incidence of cancer related lymphedema in low and middle-income countries: a systematic review and meta-analysis. BMC Cancer. 2020;20:604. https://doi.org/10.1186/s12885-020-07079-7

Bevilacqua JL, Kattan MW, Changhong Y, Koifman S, Mattos IE, Koifman RJ, et al. Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer. Ann Surg Oncol. 2012;19(8):2580-9. https://doi.org/10.1245/s10434-012-2290-x

Ribeiro Pereira ACP, Koifman RJ, Bergmann A. Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-up. Breast. 2017;36:67-73. https://doi.org/10.1016/j.breast.2017.09.006

Macedo FO. Abordagem cirúrgica axilar no câncer de mama estadiamento clínico T1- T2N0M0: complicações pós-operatórias e sobrevida em uma coorte hospitalar de mulheres do Rio de Janeiro [dissertation]. Rio de Janeiro (RJ): Escola Nacional de Saúde Pública Sergio Arouca - Fundação Oswaldo Cruz; 2015.

Jammallo LS, Miller CL, Singer M, Horick NK, Skolny MN, Specht MC, et al. Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer. Breast Cancer Res Treat. 2013;142(1):59-67. https://doi.org/10.1007/s10549-013-2715-7

Warren LE, Miller CL, Horick N, Skolny MN, Jammallo LS, Sadek BT, et al. The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study. Int J Radiat Oncol Biol Phys. 2014;88(3):565-71. https://doi.org/10.1016/j.ijrobp.2013.11.232

Sherman KA, Miller SM, Roussi P, Taylor A. Factors predicting adherence to risk management behaviors of women at increased risk for developing lymphedema. Support Care Cancer. 2015;23(1):61-9. https://doi.org/10.1007/s00520-014-2321-1

Fabro EAN, Costa RM, de Oliveira JF, Lou MBA, Torres DM, Ferreira FO, et al. Care physical therapy in control of secondary lymphedema treatment of breast cancer: routine Cancer Hospital III/National Cancer Institute. Rev Bras Mastologia. 2016;26(1):4-8. https://doi.org/10.5327/Z201600010002RBM

Ahn S, Port ER. Lymphedema precautions: Time to abandon old practices? J Clin Oncol. 2016;34(7):655-8. https://doi.org/10.1200/JCO.2015.64.9574

Ferguson CM, Swaroop MN, Horick N, Skolny MN, Miller CL, Jammallo LS, et al. Impact of ipsilateral blood draws, injections, blood pressure measurements, and air travel on the risk of lymphedema for patients treated for breast cancer. J Clin Oncol. 2016;34(7):691-8. https://doi.org/10.1200/JCO.2015.61.5948

Asdourian MS, Skolny MN, Brunelle C, Seward CE, Salama L, Taghian AG. Precautions for breast cancer-related lymphoedema: risk from air travel, ipsilateral arm blood pressure measurements, skin puncture, extreme temperatures, and cellulitis. Lancet Oncol. 2016;17(9):e392-405. https://doi.org/10.1016/S1470-2045(16)30204-2

Paramanandam VS, Roberts D. Weight training is not harmful for women with breast cancer-related lymphoedema: a systematic review. J Physiother. 2014;60(3):136-43. https://doi.org/10.1016/j.jphys.2014.07.001

Lu SR, Hong RB, Chou W, Hsiao PC. Role of physiotherapy and patient education in lymphedema control following breast cancer surgery. Ther Clin Risk Manag. 2015;2015(11):319-27. https://doi.org/10.2147/TCRM.S77669

Bergman A, Mattos IE, Koifman RJ. Diagnosis of lymphedema: analysis of the methods used in the evaluation of the upper limb in women undergoing axillary linfadenectomy for breast cancer treatment. Rev Bras Cancerol. 2004;50(4):311-20.

Torres Lacomba M, Yuste Sánchez MJ, Zapico Goñi A, Prieto Merino D, Mayoral del Moral O, Cerezo Téllez E, et al. Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomized, single blinded, clinical trial. BMJ. 2010;340:b5396. https://doi.org/10.1136/bmj. b5396

Fu MR. Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management. World J Clin Oncol. 2014;5(3):241-7. https://doi.org/10.5306/wjco.v5.i3.241

Togawa K, Ma H, Smith AW, Neuhouser ML, George SM, Baumgartner KB, et al. Self-reported symptoms of arm lymphedema and health-related quality of life among female breast cancer survivors. Sci Rep. 2021;11(1):10701. https://doi.org/10.1038/s41598-021-89055-0

Bergmann A. Prevalência de linfedema subsequente a tratamento cirúrgico para câncer de mama no Rio de Janeiro [dissertation]. Rio de Janeiro: Fundação Oswaldo Cruz, Escola de Saúde Pública; 2000.

Byun HK, Chang JS, Im SH, Kirova YM, Arsene-Henry A, Choi SH, et al. Risk of lymphedema following contemporary treatment for breast cancer: an analysis of 7,617 consecutive patients from a multidisciplinary perspective. Ann Surg. 2021;274(1):170-8. https://doi.org/10.1097/SLA.0000000000003491

Zhang Z, Zhang X, Chen S, Jiang J, Qi R, Zhang X, et al. Taxane-based chemotherapy and risk of breast cancer-related lymphedema: Protocol for a systematic review and meta-analysis. Medicine (Baltimore). 2019;98(30):e16563. https://doi.org/10.1097/MD.0000000000016563

McLaughlin SA, Brunelle CL, Taghian A. Breast cancer-related lymphedema: risk factors, screening, management, and the impact of locoregional treatment. J Clin Oncol. 2020;38(20):2341-50. https://doi.org/10.1200/JCO.19.02896

Zou L, Liu FH, Shen PP, Hu Y, Liu XQ, Xu YY, et al. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study. Breast Cancer. 2018;25(3):309-14. https://doi.org/10.1007/s12282-018-0830-3

Galimberti V, Cole BF, Viale G, Veronesi P, Vicini E, Intra M, et al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol. 2018;19(10):1385-93. https://doi.org/10.1016/S1470-2045(18)30380-2

Asdourian MS, Swaroop MN, Sayegh HE, Brunelle CL, Mina AI, Zheng H, et al. Association between precautionary behaviors and breast cancer-related lymphedema in patients undergoing. J Clin Oncol. 2017;35(35):3934-41. https://doi.org/10.1200/JCO.2017.73.7494

Showalter SL, Brown JC, Cheville AL, Fisher CS, Sataloff D, Schmitz KH. Lifestyle risk factors associated with arm swelling among women with breast cancer. Ann Surg Oncol. 2013;20(3):842-9. https://doi.org/10.1245/s10434-

- 2631-9

Gillespie TC, Sayegh HE, Brunelle CL, Daniell KM, Taghian AG. Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments. Gland Surg. 2018;7(4):379-403. https://doi.org/10.21037/gs.2017.11.04

Hasenoehrl T, Keilani M, Palma S, Crevenna R. Resistance exercise and breast cancer related lymphedema - a systematic review update. Disabil Rehabil. 2020;42(1):26-35. https://doi.or g/10.1080/09638288.2018.1514663

Keilani M, Hasenoehrl T, Neubauer M, Crevenna R. Resistance exercise and secondary lymphedema in breast cancer survivors-a systematic review. Support Care Cancer. 2016;24(4):1907-16. https://doi.org/10.1007/s00520-015-3068-z

Jammallo LS, Miller CL, Horick NK, Skolny MN, O’Toole J, Specht MC, et al. Factors associated with fear of lymphedema after treatment for breast cancer. Oncol Nurs Forum. 2014;41(5):473-83. https://doi.org/10.1188/14.ONF.473-483

Stout NL, Binkley JM, Schmitz KH, Andrews K, Hayes SC, Campbell KL, et al. A prospective surveillance model for rehabilitation for women with breast cancer. Cancer. 2012;118(8 Suppl.):2191-200. https://doi.org/10.1002/cncr.27476

Downloads

Published

2021-04-05

How to Cite

Fabro, E. A. N., Macedo, F. O., Costa, R. M., Lou, M. B. de A., Marchito, L. de O., Aguiar, S. S. de, & Bergmann, A. (2021). Guidelines for the prevention of secondary lymphedema following breast cancer treatment: adhesion and associated factors. Mastology, 31, 1–9. Retrieved from https://revistamastology.emnuvens.com.br/revista/article/view/309

Issue

Section

Original Articles